Not applicableLooking for participantsNCT06474533What this trial is testingFluoroethyltyrosine for the Evaluation of Intracranial NeoplasmWho this might be right forIntracranial Neoplasm Thomas Hope 199
Not applicableLooking for participantsNCT05954858What this trial is testingSurgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaWho this might be right forGlioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more Northwell Health 32
Large-scale testing (Phase 3)Ended earlyNCT05328908What this trial is testingNivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Bristol-Myers Squibb 770
Not applicableStudy completedNCT02537106What this trial is testingA Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and MicrocirculationWho this might be right forBrain Tumors University Hospital Hradec Kralove 100
Not applicableStudy completedNCT02261649What this trial is testingImpact of Cerebellar Mass Resection on Pain ProcessingWho this might be right forCerebellar Neoplasm Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT04264143What this trial is testingCED of MTX110 Newly Diagnosed Diffuse Midline GliomasWho this might be right forDiffuse Intrinsic Pontine GliomaDiffuse Pontine and Thalamic GliomasDiffuse Midline Glioma Luca Szalontay 9
Very early researchLooking for participantsNCT05996432What this trial is testingImage-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation TherapyWho this might be right forHead and Neck Squamous Cell CarcinomaBrain Metastases Vanderbilt-Ingram Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT04610684What this trial is testingChemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain MetastasesWho this might be right forSmall-cell Lung CancerBrain Metastases Jeffrey Clarke 3
Not applicableLooking for participantsNCT00599092What this trial is testingPituitary Tumor Surveillance: Pathogenic CorrelationWho this might be right forPituitary Tumor Cedars-Sinai Medical Center 1,250
Early research (Phase 1)Study completedNCT01975116What this trial is testingP28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsWho this might be right forTeratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more Pediatric Brain Tumor Consortium 18
Early research (Phase 1)Study completedNCT00503204What this trial is testingPhase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain TumourWho this might be right forRecurrent GlioblastomaBrain Tumor AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT00002931What this trial is testingCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell CancerWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00619112What this trial is testingTemozolomide in Treating Patients With Recurrent High-Grade GliomaWho this might be right forRecurrent Central Nervous System Neoplasm University of California, San Francisco 60
Testing effectiveness (Phase 2)UnknownNCT00492687What this trial is testingRadiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasWho this might be right forBrain and Central Nervous System Tumors San Diego Pacific Oncology & Hematology Associates 80
Testing effectiveness (Phase 2)Study completedNCT00006358What this trial is testingTemozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain TumorWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Early research (Phase 1)Ended earlyNCT00734526What this trial is testingPhase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaWho this might be right forGlioblastomaGliosarcoma M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00814463What this trial is testingStereotactic Radiosurgery After Surgery in Treating Patients With Brain MetastasesWho this might be right forMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific Duke University 1
Not applicableStudy completedNCT06417333What this trial is testingA Smart-wrist Band Connected Mobile Application for the Assessment and Management of Dementia SymptomsWho this might be right forDementia, Mild Muğla Sıtkı Koçman University 60
Not applicableStudy completedNCT03746392What this trial is testingProject to Improve Communication About Serious Illness - Pilot StudyWho this might be right forMalignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more University of Washington 150
Testing effectiveness (Phase 2)Study completedNCT01931098What this trial is testingOral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior BevacizumabWho this might be right forGlioblastomaGlioblastoma MultiformeGliosarcoma+2 more National Cancer Institute (NCI) 35